Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

176 to 200 of 319 results

Largely negative views from Germany's IQWiG on AstraZeneca's Caprelsa in thyroid cancer

26-06-2013

In a new benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) has…

AstraZenecaCaprelsaEuropeOncologyPharmaceuticalPricingRegulation

Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD

19-06-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US partner Bristol-Myers Squibb have announced mixed…

AstraZenecaBristol-Myers SquibbDiabetesNeurologicalNewron PharmaOnglyzaPharmaceuticalResearchsafinamideZambon

AstraZeneca unit links with NGM Biopharma on diabetes and obesity research

17-06-2013

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) US biologics R&D subsidiary MedImmune has entered into…

AstraZenecaBiotechnologyDiabetesLicensingMedImmuneMetabolicsNGM BiopharmaceuticalsPharmaceuticalResearch

New Zealand to fund AstraZeneca's Brilinta for acute coronary syndromes

10-06-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, says it has reached an agreement with the local…

Asia-PacificAstraZenecaBrilintaCardio-vascularPharmaceuticalPricingRegulation

AstraZeneca to pay up to $1.15 billion to acquire Pearl Therapeutics

10-06-2013

In a further "strategic" bolt-on acquisition for Anglo-Swedish drug major AstraZeneca (LSE: AZN) in less…

AstraZenecaMergers & AcquisitionsPearl TherapeuticsPharmaceuticalPT003Respiratory and Pulmonary

AstraZeneca returns fostamatinib program rights to Rigel

04-06-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US partner Rigel Pharmaceuticals (Nasdaq: RIGL) today…

Anti-Arthritics/RheumaticsAstraZenecafostamatinibLicensingPharmaceuticalResearchRigel Pharmaceuticals

$10M milestone for Isis Pharma from AstraZeneca for ISIS-ARRx to treat prostate cancer

04-06-2013

USA-based Isis Pharmaceuticals (Nasdaq: ISIS) says that Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AstraZenecaIsis PharmaceuticalsISIS-AR rxLicensingOncologyPharmaceutical

UK's NICE backs NHS use of Bristol-Myers/AstraZeneca's Forxiga

30-05-2013

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) today (May 30) issued…

AstraZenecaBristol-Myers SquibbDiabetesEuropeForxigaPharmaceuticalPricingRegulation

AstraZeneca to buy Omthera in up to $443 million deal

28-05-2013

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) new chief executive Pascal Soriot is making another…

AstraZenecaCardio-vascularEpanovaMergers & AcquisitionsOmthera PharmaceuticalsPharmaceutical

AstraZeneca plans to move three cancer drug candidates into Ph III

16-05-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning (May 16) announced that it will be moving…

AstraZenecaBiotechnologyMedImmunemoxetumomab pasudotoxolaparibOncologyPharmaceuticalResearchselumetinib

BioCity to develop BioHub at Alderley Park post AstraZeneca

07-05-2013

BioCity Nottingham, a UK provider of life sciences business incubation services, has been appointed by…

AstraZenecaBiotechnologyEuropePharmaceuticalResearch

DC Circuit Court says AstraZeneca not entitled to three-year exclusivity for Seroquel

29-04-2013

In a brief opinion handed down last week by the US Court of Appeals for the District of Columbia Circuit,…

AstraZenecaNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel

AstraZeneca sales and earning down in 1st-qtr 2013, as patent cliff bites

25-04-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has reported first-quarter 2013 financial results with…

AstraZenecaFinancialPharmaceutical

Alchemia in up to A$240 million deal with AstraZeneca for VAST discovery platform

23-04-2013

In a third drug discovery agreement in a matter of days, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlchemiaAstraZenecaLicensingPharmaceuticalResearch

Horizon Discovery signs cancer drug discovery deal with AstraZeneca

22-04-2013

In a second deal announced today (April 22), Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed…

AstraZenecaHD-001Horizon DiscoveryLicensingOncologyPharmaceuticalResearch

176 to 200 of 319 results

Back to top